Current controversies in the management of idiopathic thrombocytopenic purpura during childhood

D. Medeiros, G. R. Buchanan

Research output: Contribution to journalArticle

72 Citations (Scopus)

Abstract

Both acute and chronic ITP in children are generally benign conditions. Few patients develop serious complications or long-term sequelae. Therefore, most patients require little or no specific therapy. IVIG or high-dose steroids may benefit some patients who have evidence of clinical bleeding, and splenectomy may be of value in patients with chronic ITP whose lives are altered by low platelet counts or bleeding. It is difficult to predict which patients are at risk for the development of ICH, and severe hemorrhage is not always curtailed by prior or concomitant therapy. The decision to treat a child with ITP should be based on the entire clinical picture rather than on the platelet count alone.

Original languageEnglish (US)
Pages (from-to)757-772
Number of pages16
JournalPediatric Clinics of North America
Volume43
Issue number3
DOIs
StatePublished - 1996

Fingerprint

Idiopathic Thrombocytopenic Purpura
Inosine Triphosphate
Hemorrhage
Platelet Count
Intravenous Immunoglobulins
Splenectomy
Steroids
Therapeutics

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Current controversies in the management of idiopathic thrombocytopenic purpura during childhood. / Medeiros, D.; Buchanan, G. R.

In: Pediatric Clinics of North America, Vol. 43, No. 3, 1996, p. 757-772.

Research output: Contribution to journalArticle

@article{9bb8f87ae64a4263b5bfae119eb8732b,
title = "Current controversies in the management of idiopathic thrombocytopenic purpura during childhood",
abstract = "Both acute and chronic ITP in children are generally benign conditions. Few patients develop serious complications or long-term sequelae. Therefore, most patients require little or no specific therapy. IVIG or high-dose steroids may benefit some patients who have evidence of clinical bleeding, and splenectomy may be of value in patients with chronic ITP whose lives are altered by low platelet counts or bleeding. It is difficult to predict which patients are at risk for the development of ICH, and severe hemorrhage is not always curtailed by prior or concomitant therapy. The decision to treat a child with ITP should be based on the entire clinical picture rather than on the platelet count alone.",
author = "D. Medeiros and Buchanan, {G. R.}",
year = "1996",
doi = "10.1016/S0031-3955(05)70431-4",
language = "English (US)",
volume = "43",
pages = "757--772",
journal = "Pediatric Clinics of North America",
issn = "0031-3955",
publisher = "W.B. Saunders Ltd",
number = "3",

}

TY - JOUR

T1 - Current controversies in the management of idiopathic thrombocytopenic purpura during childhood

AU - Medeiros, D.

AU - Buchanan, G. R.

PY - 1996

Y1 - 1996

N2 - Both acute and chronic ITP in children are generally benign conditions. Few patients develop serious complications or long-term sequelae. Therefore, most patients require little or no specific therapy. IVIG or high-dose steroids may benefit some patients who have evidence of clinical bleeding, and splenectomy may be of value in patients with chronic ITP whose lives are altered by low platelet counts or bleeding. It is difficult to predict which patients are at risk for the development of ICH, and severe hemorrhage is not always curtailed by prior or concomitant therapy. The decision to treat a child with ITP should be based on the entire clinical picture rather than on the platelet count alone.

AB - Both acute and chronic ITP in children are generally benign conditions. Few patients develop serious complications or long-term sequelae. Therefore, most patients require little or no specific therapy. IVIG or high-dose steroids may benefit some patients who have evidence of clinical bleeding, and splenectomy may be of value in patients with chronic ITP whose lives are altered by low platelet counts or bleeding. It is difficult to predict which patients are at risk for the development of ICH, and severe hemorrhage is not always curtailed by prior or concomitant therapy. The decision to treat a child with ITP should be based on the entire clinical picture rather than on the platelet count alone.

UR - http://www.scopus.com/inward/record.url?scp=0029977309&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029977309&partnerID=8YFLogxK

U2 - 10.1016/S0031-3955(05)70431-4

DO - 10.1016/S0031-3955(05)70431-4

M3 - Article

C2 - 8649908

AN - SCOPUS:0029977309

VL - 43

SP - 757

EP - 772

JO - Pediatric Clinics of North America

JF - Pediatric Clinics of North America

SN - 0031-3955

IS - 3

ER -